Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
92.71
-0.02 (-0.02%)
Feb 27, 2026, 3:00 PM CST

SHA:688578 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
41,72026,95518,7478,85613,59012,816
Market Cap Growth
34.85%43.78%111.69%-34.83%6.04%-
Enterprise Value
38,44523,92716,4946,91611,01512,083
Last Close Price
92.7159.4540.8419.2929.6127.92
PE Ratio
19.1218.8529.1067.85743.66-
Forward PE
18.1517.6428.7074.26109.82-
PS Ratio
8.077.589.2911.2025.6422849.52
PB Ratio
6.425.104.712.784.574.45
P/TBV Ratio
6.605.174.792.844.684.56
P/FCF Ratio
-20.8030.90---
P/OCF Ratio
-17.2127.7996.65463.96-
EV/Sales Ratio
7.436.738.178.7420.7821543.30
EV/EBITDA Ratio
14.7515.8328.18117.62--
EV/EBIT Ratio
14.9616.2230.08179.00--
EV/FCF Ratio
-18.4727.18---
Debt / Equity Ratio
0.00000.000.00-
Debt / EBITDA Ratio
0.000.000.000.03--
Debt / FCF Ratio
0.000.000.00---
Net Debt / Equity Ratio
-0.50-0.69-0.63-0.64-0.76-0.90
Net Debt / EBITDA Ratio
-1.61-2.40-4.29-34.6140.267.41
Net Debt / FCF Ratio
-1.74-2.80-4.1438.9913.849.09
Asset Turnover
0.750.690.520.240.170
Inventory Turnover
4.763.622.321.781.900.03
Quick Ratio
4.886.737.188.6214.5923.80
Current Ratio
5.396.967.468.9815.2124.58
Return on Equity (ROE)
34.90%30.86%17.97%4.24%0.63%-15.29%
Return on Assets (ROA)
19.70%17.91%8.77%0.73%-1.43%-10.48%
Return on Invested Capital (ROIC)
63.82%83.25%41.02%4.13%-13.81%-114.09%
Return on Capital Employed (ROCE)
30.70%27.70%13.80%1.20%-2.30%-12.60%
Earnings Yield
5.23%5.30%3.44%1.47%0.13%-2.42%
FCF Yield
-4.81%3.24%-0.59%-1.20%-2.23%
Dividend Yield
0.86%1.09%0.98%---
Payout Ratio
-20.46%----
Buyback Yield / Dilution
0.14%0.18%-0.09%1.49%-23.59%-2.30%
Total Shareholder Return
0.98%1.28%0.89%1.49%-23.59%-2.30%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.